Do you want to read an article? Please log in or register.
Efficacy of Indacaterol vs Tiotropium in COPD patients due to biomass exposure in improving quality of life and reducing symptoms
COPD
RECOMMENDED
Related content
COPD
Dupilumab reduces acute exacerbations and improves lung function in patients with COPD with type 2 inflammation irrespective of body mass index, airflow obstruction, dyspnea, and exercise capacity index scores
Respir Med
Vogelmeier CF, Rabe KF, Bhatt SP, Hanania NA, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Maloney J, Dakin P, Lu X, Bauer D, Bansal A, Robinson LB, Abdulai RM
doi: 10.1016/j.rmed.2025.108015
RECOMMENDED
Asthma
Risk Factors Associated with Asthma Control and Quality of Life in Patients with Mild Asthma Without Preventer Treatment, a Cross-Sectional Study
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Asthma Allergy
Eriksson S, Giezeman M, Hasselgren M, Janson C, Kisiel MA, Montgomery S, Nager A, Sandelowsky H, Ställberg B, Sundh J, Lisspers K
doi: 10.2147/JAA.S460051
ERS 2024
Asthma
BEHAVE: Benralizumab reduces exacerbations and improves asthma control in real-world patients with severe asthma
Further Publications
Efficacy of respiratory muscle training in improving pulmonary function and survival in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis
Ther Adv Respir Dis
Benzo-Iglesias MJ, Rocamora-Pérez P, Valverde-Martínez MLÁ, García-Luengo AV, Benzo-Iglesias PM, López-Liria R
doi: 10.1177/17534666251346095
ARDS
Long-Term Health-Related Quality of Life Following Survival of Acute Respiratory Distress Syndrome and Extracorporeal Membrane Oxygenation Due to COVID-19
J Clin Med
Hermann M, Filipsky R, Bukowski N, Gerger G, Hermann A, Krenn K, Teufel A, Kimberger O, Laxar D, Maleczek M, Schaden E, Wiegele M, Willschke H, Tiboldi A
doi: 10.3390/jcm14103358
COPDEmphysema
Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS)
Respir Med
Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Dakin P, Maloney J, Lu X, Bauer D, Bansal A, Robinson LB, Abdulai RM
doi: 10.1016/j.rmed.2024.107846
COPD
Post-Acute Care Interventions in Patients Hospitalized Due to COPD Exacerbation Before and After Implementation of an Integrated Care Program
Int J Chron Obstruct Pulmon Dis
Hübsch C, Clarenbach CF, Franzen DP, Schmid-Mohler G
doi: 10.2147/COPD.S496167
RECOMMENDED
COPD
Use of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitor is Associated with reduced Emergency Room Visits and Hospitalization in Patients with Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Diabetes Mellitus
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Shanmugavel Geetha H, Teo YX, Ravichandran S, Perkitt NR, Gogtay M, Lal A, Abraham GM, Trivedi N
doi: 10.1016/j.rmed.2024.107819
RECOMMENDED
Sleep Apnea
Patient-Reported Quality of Life Outcomes with Mandibular Advancement versus CPAP: Insights from the CRESCENT Trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Sleep
Colpani JT, Ou YH, Thakumar AV, Cheong CS, Loke W, Sia CH, Teo YH, Chan SP, Chin CW, Kojodjojo P, Chan MY, Cistulli PA, Luo N, Lee CH
doi: 10.1093/sleep/zsaf022